Baxter International

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.  The company operates through three segments: BioScience, Medication Delivery, and Renal. Patients and providers rely on Baxter for lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.

Company Growth (employees)
Deerfield, US
Size (employees)
48,000 (est)-4%
Baxter International was founded in 1931 and is headquartered in Deerfield, US

Key People at Baxter International

Robert Parkinson

Robert Parkinson

Chairman & CEO
James K. Saccaro

James K. Saccaro

Tomas  F. Chen

Tomas F. Chen

Paul E. Martin

Paul E. Martin

Jeanne K. Mason

Jeanne K. Mason

VP of HR

Baxter International Office Locations

Baxter International has offices in Deerfield, Ho Chi Minh City, Minneapolis, Newbury and in 40 other locations
Deerfield, US
Tianjin, CN
New York, US
Lombard, US
Houston, US
Baltimore, US
Bloomington, US
Miami, US
Chengdu, CN
Taipei, TW
Cambridge, US
Gurgaon, IN
Swedesboro, US
Moscow, RU

Baxter International Metrics

Baxter International Summary

Market capitalization

$27.7 b

Closing share price

Baxter International's current market capitalization is $27.7 b.

Baxter International Financials

Baxter International's revenue is $10.2 b in FY, 2016 which is a 2% increase from the previous period.
FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


$15.3 b$16.7 b$10 b$10.2 b

Revenue growth, %


Gross profit

$7.6 b$8.2 b$4.1 b


$2.5 b$2.4 b$449 m

Net Income

$2 b$2.5 b$968 m$5 b

Operating cash flow

($537 m)$192 m($712 m)

Baxter International Market Value History

Baxter International Online Presence

Baxter International News

Baxter International Company Life

You may also be interested in